Qlaris Bio
PrivateLast Round
Seed Round
Jun 17, 2026
Total Funding Raised
$49M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qlaris Bio is a biotechnology company that develops innovative, first-in-class therapies for serious and debilitating ophthalmic diseases, with a primary focus on glaucoma and ocular hypertension.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qlaris Bio Comparables
Compare Qlaris Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Betaliq, Inc. | 83% | |
| Bayer AG | 82% | |
| Peregrine Ophthalmic | 74% |
Qlaris Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jun 17, 2026 | ||||
| Series B | Apr 30, 2024 | ||||
| Series A | Aug 1, 2019 |
Key People
Founding team and executive leadership
Qlaris Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Leaf Venture Partners | Series B, Series A |
| abrdn Inc. | Series B |
| Mayo Clinic Ventures | Series B |
| Canaan Partners | Series B, Series A |
| Aberdeen | Series B |
| Mayo Clinic Ventures | Series B |
| Correlation Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 493% MoM, reaching 2.8K.
- Jun 17, 2026
Raised $4M in a Seed Round.
Qlaris Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qlaris Bio's valuation, stock price, and market status.
Is Qlaris Bio a public or private company?
Qlaris Bio is a private company.
What is the current stock price of Qlaris Bio?
Qlaris Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Qlaris Bio worth (valuation)?
Valuation information for Qlaris Bio is not publicly available.
Can I buy Qlaris Bio stock?
Qlaris Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Qlaris Bio's last funding round?
Qlaris Bio's most recent funding round was Seed Round on June 17, 2026.
Who are the main investors in Qlaris Bio?
Key investors in Qlaris Bio include New Leaf Venture Partners, Canaan Partners.
Will Qlaris Bio IPO soon?
No public IPO plans have been announced for Qlaris Bio.
How can I track Qlaris Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Qlaris Bio's secondary market activity and sign up for updates.